# OccuRx: Research, Melbourne, Australia

> OccuRx: OccuRx is an Australian biopharmaceutical company based in Melbourne, founded in 2014. Based in Melbourne, Australia. Founded 2014.

Source: https://millionrounds.com/startup/occurx (Millionrounds; every figure on the page links to its filing or article)

Australia · [Research startup](https://millionrounds.com/companies)

# OccuRx

OccuRx is an Australian biopharmaceutical company based in Melbourne, founded in 2014.

Funding reported Last round: Series B

Research Melbourne, Australia

Company summary

- **Founded:** 2014 12 years old
- **Team:** 1 1 to 10 people
- **Funding reported:** 21.2M as listed, currency not stated
- **Last round:** Series B Sept 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for OccuRx has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About OccuRx

OccuRx is an Australian biopharmaceutical company based in Melbourne, founded in 2014.

The company specializes in developing precision therapies aimed at treating inflammatory and fibrotic diseases, particularly through the inhibition of GPR68. OccuRx focuses on identifying novel targets to prevent fibrosis, which can lead to disease progression and organ failure, using biomarkers and genetic analysis to inform its pipeline. The company's leading product is OCX063, a first-in-class oral drug candidate that has completed Phase 1 clinical trials. This therapy is designed to prevent abnormal blood vessel growth and reduce inflammation in conditions such as focal segmental glomerulosclerosis (FSGS) and other fibrotic diseases affecting the kidneys and eyes. OccuRx also has a broader pipeline targeting GPR68 for various conditions, including scleroderma and chronic kidney disease. The company has developed investigational drugs and therapeutic strategies for the healthcare and pharmaceutical industries, emphasizing the role of fibrosis in disease pathology.

## What company datasets say OccuRx raised

Funding, as reported

Reported in all **21.2M** in the source's currency

Rounds **4**

Last round **Series B**

Last round size **16M**

Last round date **Sept 2022**

Investors listed **5**

## The company, in detail

What they build

Known for

treatment efficacy health care certa therapeutics biotechnology research pharmaceutical pipeline inflamed pathways safety studies translational research diabetic retinopathy connective tissue disorders systemic sclerosis focal segmental glomerulosclerosis hospital & health care medical affairs phase ii trials biomarkers

Built with from their website

Amazon AWS Google Search Console

- **Sector:** Research
- **Industry code:** NAICS 54171, SIC 2834
- **Region:** Victoria
- **Part of:** Certa Therapeutics
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/occurx)

## Research in Australia

Startups like it

- [**PolyActiva** Melbourne · founded 2010 *Raised*](https://millionrounds.com/company/polyactiva)
- [**Ferronova** Adelaide · founded 2016 *Raised*](https://millionrounds.com/company/ferronova)
- [**Nbryo** Brisbane · founded 2020 *Raised*](https://millionrounds.com/company/nbryo)
- [**Fremantle Seaweed** Perth *Raised*](https://millionrounds.com/company/fremantle-seaweed)
- [**Bovotica** Brisbane · founded 2023 *Raised*](https://millionrounds.com/company/bovotica)
- [**Bower** Byron Bay · founded 2025 *Raised*](https://millionrounds.com/company/bower)
- [**Levur** Sydney · founded 2023 *Raised*](https://millionrounds.com/company/levur)
- [**Cell Bauhaus** Melbourne · founded 2023 *Raised*](https://millionrounds.com/company/cell-bauhaus)

## Is this your company?

Add your raise, your deck and your story, and put OccuRx in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)